UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Repeated Measurements and Cross-Over Designs

1, 2014

Volltextzugriff (PDF)

Practical Statistical Methods: A SAS Programming Approach

Padgett, Lakshmi

1, 2011

Volltextzugriff (PDF)

Ustekinumab in Paediatric Patients with Moderately to Severely Active Crohn’s Disease: Pharmacokinetics, Safety, and Efficacy Results from UniStar, a Phase 1 Study

Journal of Crohn's and colitis, 2021-11, Vol.15 (11), p.1931-1942

2021

Volltextzugriff (PDF)

Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic Stroke: Results of an International Phase III Trial : Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II)

Stroke (1970), 2008, Vol.39 (1), p.87-99

2008

Volltextzugriff (PDF)

1164 EFFICACY, SAFETY, TOLERABILITY OF USTEKINUMAB IN PEDIATRIC PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: RESULTS FROM UNISTAR, A PHASE 1 STUDY

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-235-S-236

2020

Volltextzugriff (PDF)

615 PHARMACOKINETICS OF USTEKINUMAB IN CHILDREN AND ADOLESCENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: RESULTS FROM UNISTAR, A PHASE 1 STUDY

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-131-S-132

2020

Volltextzugriff (PDF)

Subcutaneous Golimumab in Pediatric Ulcerative Colitis: Pharmacokinetics and Clinical Benefit

Inflammatory bowel diseases, 2017-12, Vol.23 (12), p.2227-2237

2017

Volltextzugriff (PDF)

Pharmacokinetics of infliximab in children with moderate-to-severe ulcerative colitis: results from a randomized, multicenter, open-label, phase 3 study

Inflammatory bowel diseases, 2013-12, Vol.19 (13), p.2753-2762

2013

Volltextzugriff (PDF)

Long-Term Benefit of Golimumab for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the PURSUIT-Maintenance Extension

Journal of Crohn's and colitis, 2018-08, Vol.12 (9), p.1053-1066

2018

Volltextzugriff (PDF)

631 A Multi-Center Open-Label Study Assessing Pharmacokinetics, Efficacy, and Safety of Subcutaneous Golimumab in Pediatric Patients With Moderately-Severely Active Ulcerative Colitis

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S132-S132

2016

Volltextzugriff (PDF)

Maintenance of Efficacy and Continuing Safety of Golimumab for Active Ulcerative Colitis: PURSUIT-SC Maintenance Study Extension Through 1 Year

Clinical and translational gastroenterology, 2016-04, Vol.7 (4), p.e168-e168

2016

Volltextzugriff (PDF)

Sa1161 Impact-III Demonstrates Excellent Sensitivity in Reflecting Clinical Change in the T72 Trial of Infliximab for Pediatric Ulcerative Colitis

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-216-S-216

2014

Volltextzugriff (PDF)

Su1923 Pharmacokinetics and Exposure-Response Relationships of Golimumab in Pediatric Patients With Moderate to Severe Ulcerative Colitis: Results From a Multicenter Open Label Study

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S590-S590

2016

Volltextzugriff (PDF)

Mo1790 Safety, Efficacy, and Pharmacokinetics of Golimumab in Patients with Moderately to Severely Active Ulcerative Colitis: PURSUIT-SC Long term Extension

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S776-S777

2016

Volltextzugriff (PDF)

Treating Patients With 'Wake-Up' Stroke : The Experience of the AbESTT-II Trial

Stroke (1970), 2008-12, Vol.39 (12), p.3277-3282

2008

Volltextzugriff (PDF)

Maintenance Golimumab Treatment in Pediatric UC Patients With Moderately to Severely Active UC: PURSUIT PEDS PK Long-Term Study Results

Crohn's & colitis 360, 2020-10, Vol.2 (4), p.otaa063-otaa063

2020

Volltextzugriff (PDF)

Mo1214 Long-Term Safety and Efficacy of Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the PURSUIT-SC Maintenance Study Extension

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-587-S-587

2014

Volltextzugriff (PDF)

Continuous Normal Data

Practical Statistical Methods, 2011, p.72-145

Padgett, Lakshmi

2011

Volltextzugriff (PDF)

Introduction

Practical Statistical Methods, 2011, p.16-35

Padgett, Lakshmi

2011

Volltextzugriff (PDF)

Regression

Practical Statistical Methods, 2011, p.172-241

Padgett, Lakshmi

2011

Volltextzugriff (PDF)

Miscellaneous Topics

Practical Statistical Methods, 2011, p.242-293

Padgett, Lakshmi

2011

Volltextzugriff (PDF)

Nonparametric Methods

Practical Statistical Methods, 2011, p.146-171

Padgett, Lakshmi

2011

Volltextzugriff (PDF)

Qualitative Data

Practical Statistical Methods, 2011, p.36-71

Padgett, Lakshmi

2011

Volltextzugriff (PDF)

Introduction

Practical Statistical Methods, 2011

Padgett, Lakshmi

2011

Volltextzugriff (PDF)

References and Selected Bibliography

Practical Statistical Methods, 2011

Padgett, Lakshmi

2011

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(42)

Publikationsform

Sprache

Englisch
(42)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Repeated Measurements and Cross-Over Designs

Practical Statistical Methods: A SAS Programming Approach

Ustekinumab in Paediatric Patients with Moderately to Severely Active Crohn’s Disease: Pharmacokinetics, Safety, and Efficacy Results from UniStar, a Phase 1 Study

Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic Stroke: Results of an International Phase III Trial : Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II)

1164 EFFICACY, SAFETY, TOLERABILITY OF USTEKINUMAB IN PEDIATRIC PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: RESULTS FROM UNISTAR, A PHASE 1 STUDY

615 PHARMACOKINETICS OF USTEKINUMAB IN CHILDREN AND ADOLESCENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: RESULTS FROM UNISTAR, A PHASE 1 STUDY

Subcutaneous Golimumab in Pediatric Ulcerative Colitis: Pharmacokinetics and Clinical Benefit

Pharmacokinetics of infliximab in children with moderate-to-severe ulcerative colitis: results from a randomized, multicenter, open-label, phase 3 study

Long-Term Benefit of Golimumab for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the PURSUIT-Maintenance Extension

631 A Multi-Center Open-Label Study Assessing Pharmacokinetics, Efficacy, and Safety of Subcutaneous Golimumab in Pediatric Patients With Moderately-Severely Active Ulcerative Colitis

Maintenance of Efficacy and Continuing Safety of Golimumab for Active Ulcerative Colitis: PURSUIT-SC Maintenance Study Extension Through 1 Year

Sa1161 Impact-III Demonstrates Excellent Sensitivity in Reflecting Clinical Change in the T72 Trial of Infliximab for Pediatric Ulcerative Colitis

Su1923 Pharmacokinetics and Exposure-Response Relationships of Golimumab in Pediatric Patients With Moderate to Severe Ulcerative Colitis: Results From a Multicenter Open Label Study

Mo1790 Safety, Efficacy, and Pharmacokinetics of Golimumab in Patients with Moderately to Severely Active Ulcerative Colitis: PURSUIT-SC Long term Extension

Treating Patients With 'Wake-Up' Stroke : The Experience of the AbESTT-II Trial

Maintenance Golimumab Treatment in Pediatric UC Patients With Moderately to Severely Active UC: PURSUIT PEDS PK Long-Term Study Results

Mo1214 Long-Term Safety and Efficacy of Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the PURSUIT-SC Maintenance Study Extension

Continuous Normal Data

Introduction

Regression

Miscellaneous Topics

Nonparametric Methods

Qualitative Data

Introduction

References and Selected Bibliography

Suchergebnisse filtern